Creidt: Leigh Prather/Adobe Stock Shareholder Says COVID Vaccine Hopeful's Board Knew Drug Wouldn't Succeed
Maryland-based Novavax is the second company to be sued in the Court of Chancery for leading investors to believe vaccine testing and production was going better than it was.
December 08, 2022 at 04:23 PM
3 minute read
Securities Litigation
A shareholder has filed a lawsuit against officers and directors of Novavax Inc. on Wednesday, claiming they misled the public about the likelihood of developing and selling a vaccine for COVID-19 to reap millions in personal gains.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 3'That's Disappointing': Only 11% of MDL Appointments Went to Attorneys of Color in 2023
- 4What We Know About the Kentucky Judge Killed in His Chambers
- 5'I'm Staying Everything': Texas Bankruptcy Judge Halts Talc Trials Against J&J
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
